Portugal will subsidise 15% of obesity medications

The state has established a 15% co-payment for obesity medications. To qualify, patients must be enrolled in a multidisciplinary hospital monitoring program (EMO) at their Local Health Unit (ULS) and receive the prescription from a specialist in endocrinology, internal medicine, or paediatrics.


